Despite the advent of conventional stents as a major breakthrough in the treatment of peripheral artery disease and coronary artery diseases, these devices permanently remain in the body. Issues with implantation of conventional stents include but are not limited to mechanical blockages, malposition, and late restenosis and so on. A key prediction for interventional cardiology coming out form cardiologists and respective associations is that bioabsorbable stents will eventually replace the conventional bare metal stents.
The peripheral vascular stents market is expected to witness a CAGR of 7.5% during the forecast period of 2025 to 2033, driven by the increasing prevalence of peripheral artery disease (PAD) and the rising aging population. Peripheral vascular stents are medical devices used to treat blockages and narrowings in peripheral arteries, such as those in the legs, arms, and other areas outside the heart and brain. The main purpose of these stents is to restore blood flow and prevent further complications associated with PAD, such as limb amputations and cardiovascular events.
The report titled “Vital Signs Monitoring Devices Market: Growth, Future Prospects, and Competitive Analysis, 2017 -2025” offers strategic insights into the overall vital signs monitoring devices market along with the market size and estimates for the duration 2015 to 2025. The said research study covers in-depth analysis of vital signs monitoring devices market segments based on product type, end consumers and different geographies further segmented by countries.
According to the WHO studies, around 1.7 million people are infected with hepatitis B virus, up to 315,000 with hepatitis C virus and as many as 33,800 with HIV through an unsafe injection. The WHO has provided new guidelines for injection safety practices to protect the healthcare professional against accidental needle injury and consequent exposure to infection.
Glaucoma refers to a chronic degenerative disease and is deemed as the second leading cause of blindness (WHO). It is further estimated that over 60 Mn suspected glaucoma cases are prevalent worldwide. Medication has remained a mainstay of glaucoma treatment for a long time.
The heart valve devices market reached $10 billion in 2021 and is expected to grow at a CAGR of 13.5% during the forecast period of 2025 to 2033. Implantation of heart valve devices is one of the most common operations used for the treatment of a blockage in the heart valves, which is why these devices are utilized in the first place. Mechanical heart valves, biological heart valves, and transcatheter heart valves are the three primary types of structural heart valve technology that are now available on the market.
This report on global ambulatory care services market studies various services and surgery of the ambulatory care market. The main need arises as it is the only viable alternative to inpatient care. Chronic disease are on a rise worldwide and so increasing the pressure to reduce healthcare cost regarding treatment and hospitalization.
The cerebrospinal fluid (CSF) management market refers to the market for devices and treatments used in the management and regulation of cerebrospinal fluid in the human body. Cerebrospinal fluid is a clear fluid that surrounds and protects the brain and spinal cord, acting as a cushioning and nourishing agent. CSF management is crucial in the treatment of various medical conditions and disorders, including hydrocephalus (excessive accumulation of CSF), intracranial pressure (increased pressure inside the skull), and cerebrospinal fluid leaks.
Percutaneous coronary intervention (PCI) is a non-surgical procedure utilized to treat coronary artery disease. A balloon catheter and coronary stents are used to remove the plaque and treat narrowing of blood vessels. In a PCI procedure, a coronary guidewire is used to direct the balloon catheter to the site of plaque in the coronary artery. A balloon catheter is thereafter inserted into the coronary artery of the heart and inflated at the site of the plaque.
Intravenous Solutions Market is Expected to Grow at 8.0% by 2033. Intravenous solutions present a combination of nutrients that support patients to get essential nutrition. The demand for intravenous solutions on the global front is undergoing steady growth and its market presents a higher growth in the Asia-Pacific region.
The market size for Healthcare Services was assessed at USD 10.3 Trillion in 2021 and is projected to reach USD 21.06 Trillion by 2030, expanding at a CAGR of 8.30% between 2022 and 2030. The market for healthcare services and technology is expanding fast, creating possibilities, hazards, and structural problems for enterprises in the industry and those in the healthcare value chain as a whole. Given that healthcare improvement potential exceeds $500 billion, the future growth potential of the healthcare services and technology business is considerable.
To establish frictionless markets for healthcare products and services, for instance, large-scale platform players could emerge. These participants could also become ecosystem integrators, integrating a variety of healthcare products and services, allowing consumers (patients and their families) to better manage their own healthcare.
The increase in the number of aged people, accelerated economic growth, technical advances, alterations in lifestyles, and improved ability to survive and level of living is anticipated to contribute to the expansion of the Healthcare Services Market. Raising the declaration of bundled payments, employing digital tools, expanding cross-industry and cross-company relationships, focusing on the creation of novel pharmaceuticals, and acquiring hybrid imaging techniques are all significant trends in the Healthcare Services Market. In recent decades, the price of medical facilities has climbed substantially.
Acute Market Reports' areas of expertise as a market research and strategic consulting organization have an undiluted focus on the healthcare service domain. Acute Market Reports' clients gain from our innovative and futuristic research methodology, which helps them make educated business decisions in a timely manner. In order to provide our international customers with innovative strategic research solutions, we engage with a wide range of industry participants.